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Abstract
This  study  presents  new thin-film solid  phase  microextraction  (SPME)  devices  prepared  on 
plastic as potential single-use samplers for bioanalysis.  Polybutylene terephthalate (PBT) was 
selected as a support due to its well-known chemical resistance, low cost, and suitability as a 
material for different medical grade components. The herein proposed samplers were prepared 
by applying a hydrophilic-lipophilic balanced (HLB) - polyacrylonitrile (PAN) coating on rounded 
and flat PBT pieces previously sanded with regular sandpaper. SPME devices prepared on PBT 
were  evaluated  in  terms  of  robustness,  chemical  stability,  and  possible  interferences  upon 
exposure to different solvents and matrices. Rewarding results were found when these samplers 
were  employed  for  the  quantitative  analysis  of  multiple  doping  substances  in  common 
biological matrices such as urine, plasma, and whole blood. Finally, the proposed thin-film SPME 
devices made on a PBT were evaluated by conducting multiple extractions from whole blood 
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and plasma using the Concept 96 system. Results showed that more than 20 extractions from 
plasma and whole blood can be performed without observed decreases in coating performance 
or peeling of the extraction phase from the plastic surface. These findings demonstrate the 
robustness  of  PAN-based  coatings  applied  on  such  polymeric  substrate,  and  open  up  the 
possibility  of  introducing  new  alternatives  and  cost-effective  materials  as  support  to 
manufacture SPME biocompatible devices for a wide range of applications, particularly in the 
clinical field.
Key words: thin-film, solid phase microextraction, high throughput, disposable sampler, sample 
preparation, polybutylene terephthalate, PBT
Introduction
Solid  phase  microextraction  (SPME)  has  demonstrated  unquestionable  advantages  as  an 
alternative sample preparation approach over traditional methods for several applications (e.g. 
liquid-liquid extraction and protein precipitation). Minimum solvent use, integration of sampling 
and  sample  preparation  steps,  simple  operation,  and  suitability  for  on-site  and  in  vivo 
determinations are just some of the important benefits of using SPME. Indeed, the introduction 
of biocompatible coatings suitable for direct extraction of diverse compounds from complex 
matrices has led to an expansion in SPME applications, especially in the field of bioanalysis. 1–6 
These  coatings,  which  consist  of  a  biocompatible  binder  used  to  immobilize  solid  phase 
extraction (SPE) particles and other sorbents, have demonstrated great selectivity towards small 
molecules, minimum or negligible protein fouling,  and sufficient stability even for long-term 
reusability (140 extractions from plasma).7,8 
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Biocompatible SPME coatings are available in two main configurations: fibers and thin-films. The 
term “thin-film” is used to designate another geometry of SPME, in which devices consisting of  
a large coated surface area and a thin coating thickness (large extraction phase surface area-to-
volume ratio) provide better sensitivity than traditional SPME fibers without sacrificing analysis 
time (short equilibration times).9 Both, fiber and thin-film SPME devices, have been subjected to 
automation for high throughput analysis in the 96-well plate format; however, the enhanced 
sensitivity  offered by thin-film geometry is  preferred in  several  cases  (e.g. in  vitro biofluids 
analysis).  Various  studies  reporting on the suitability  of  high-throughput  thin-film SPME for 
analytical determinations in different matrices have been published recently.10–12 In the area of 
bioanalysis,  some recently  reported  applications  of  thin-film SPME include  for  instance  the 
determination  of  tranexamic  acid  and  rocuronium  bromide  in  plasma,  and  the  analysis  of 
multiple  doping  substances  in  both  urine  and  plasma  samples.13–15 Although,  as  already 
emphasized,  the  robustness  of  these  biocompatible  devices  allows  for  reusability  even  in 
complex  matrices,  in  some  cases  (e.g.  doping  analysis),  it  is  certainly  preferable,  if  not 
mandatory,  to  use  disposable  or  single-use  samplers.  In  this  sense,  exploring  alternative 
materials for the construction of SPME devices, as well as simplifying the manufacturing process 
itself,  are  key  factors  to  facilitate  the  widespread  acceptance  of  this  sample  preparation 
method. 
The  introduction  of  novel  materials  in  the  fabrication  of  SPME  samplers  has  been  mainly 
directed towards finding alternative and cost-effective coating types.16–18 However, broadening 
the current list of substrate materials used to immobilize different SPME extraction phases can 
also  provide  unique  opportunities.  While  self-supported  SPME  samplers  (e.g. 
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polydimethylsiloxane sheet  pieces  (PDMS))  are  available  for  selected  applications,9,19 a  solid 
substrate is typically required as base for application of the SPME coating, as well as to define 
the device geometry (e.g. wire or monofilament type of substrate for traditional SPME fibers, 
flat supports for thin-films and blade spray devices, and a metallic mesh for SPME-transmission 
mode).20–22 Fused silica, StableFlex™, and metal non-ferrous alloys such as nitinol have been all  
used as fiber cores for  gas chromatography (GC)-amenable SPME coatings (Table S1),  while 
stainless steel and nitinol are currently employed as substrate materials of choice to immobilize 
biocompatible  extraction  phases.16–18 Despite  the  satisfactory  performance  of  biocompatible 
SPME samplers manufactured on such supports, certain applications will definitely benefit from 
the introduction of biocompatible substrates that are cheaper to manufacture, in addition to 
being more flexible, and easier to mold. For example, while the original in vivo SPME approach 
involves  the  use  of  traditional  fibers  by  exposing  them  directly  to  the  bloodstream  or  by 
inserting them in different types of tissue, 23–26 the development of devices for less invasive in  
vivo applications,  such  as  saliva  and  mucosa  analysis,  might  require  alternative  support 
materials.
Various requirements should be fulfilled when looking for substitute materials to manufacture 
SPME devices for bioanalysis.  First  of all,  the material  should be biocompatible, suitable for  
sterilization, and able to handle temperatures normally employed to cure the polymeric binders 
used for SPME coatings. Once applied, the coating should be sufficiently stable on the substrate,  
and ideally, the coated material should not release any type of interferences, neither in the 
sample nor in the desorption medium. Substitute support materials for SPME should also offer  
good  chemical  resistance,  low  moisture  absorption,  affordability,  and  be  easily  accessible. 
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Several  materials,  including  metals  and  polymers,  are  used  to  manufacture  various 
commercially  available  medical  devices.27,28 Among  this  list  of  medical  grade  materials, 
thermoplastics  represent  an  important  group  of  polymers  that  are  widely  used  for  the 
production of healthcare components.27,28 Given that these plastics display many of the features 
required for the preparation of SPME samplers, in this work, polybutylene terephthalate (PBT) 
was tested as a potential support for application of SPME biocompatible extraction phases. For 
this  purpose,  coating  preparation  conditions  were  modified  according  to  the  new  support 
material  characteristics,  and thin-film SPME devices  were  prepared using  two different  PBT 
geometries:  rounded and flat.  In  this  study,  an SPME coating made of  hydrophilic-lipophilic 
balanced particles (HLB) and polyacrylonitrile (PAN) was selected due to its suitability to extract  
a wide range of compounds.15 A thorough evaluation of the newly prepared samplers in terms 
of stability, reproducibility, and performance in the extraction of seventeen doping substances 
from various  biological  matrices  (urine,  plasma,  and whole  blood)  is  herein  presented.  The 
model compounds chosen for this work covered logarithmic octanol-water partition coefficients 
(log P) values ranging from 0.33 to 6.56, and included drugs bearing on their structure different 
moieties.  Figures  of  merit  corresponding  to  determinations  of  total  concentrations  of  the 
selected analytes spiked in different biofluids are also reported.  Lastly,  this work presents a 
discussion regarding the impact of sorbent type on coating wettability; a comparison of water 
contact angles measured on HLB-PAN, C18-PAN, and only-PAN coatings provided remarkable 





The  following  compounds  were  selected  as  model  analytes  to  evaluate  the  SPME-HLB-PBT 
devices:  amphetamine,  17-α-trenbolone,  benzoylecgonine,  bisoprolol, clenbuterol, codeine, 
exemestane, GW501516,  methamphetamine,  metoprolol,  morphine,  nikethamide, propanolol, 
salbutamol,  stanozolol,  strychnine, and toremifene.  Codeine-d3, oxycodone-d3, cannabidiol-d3, 
methadone-d3,  (±)11-nor-9-carboxy-Δ9-THC-d3  (THCCOOH-d3),  testosterone-d3 and salbutamol-
d3 were used as internal standards. Further details about compounds suppliers and properties, 
as  well  as  information  about  other  materials  and supplies,  are  provided in  the  Supporting 
Information (Table S2). 
Preparing thin-film SPME devices on PBT support
Rounded PBT pieces were trimmed to a 53 mm length. In the case SPME-HLB-PBT devices on 
flat support,  rectangular  PBT pieces with a 0.5 mm thickness (10 x 8 cm) were cut using a  
conventional paper trimmer. Prior to the application of the coating, the area to be coated was 
uniformly sanded using commercial sandpaper (first using a sandpaper of a medium macro grit 
(P150) and then using one of ultra-fine micro grit (1500)). All  PBT pieces were cleaned with 
methanol and acetonitrile (20 min in each solvent under sonication), and then left to dry at  
room temperature. 
For the coating procedure, a slurry was prepared by mixing approximately 0.7 g of HLB particles, 
3 mL of DMF, and 10 mL of 7 % (w/w) PAN/DMF solution (prepared by mixing PAN with DMF,  
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and heating the obtained solution at  90 ˚C for 1 h).  A 2 cm length coating was applied by 
spraying uniform layers of slurry and curing each layer at 125 ˚C for 2.5 min (14 cycles in total) 
(Figures 1A, 1B and 1C). From the coated rectangular pieces, SPME-HLB-PBT samplers with a 2.3 
mm width were cut using a paper trimmer as well. Six of these devices were over-coated with 
PAN by dipping them in 7 % PAN solution, as reported in the literature.29 Finally, twelve SPME-
HLB-PBT devices on flat support (6 of them over-coated with PAN) were arranged to ensure 
compatibility with the Concept 96 system, as shown in Figure 1D. All the SPME devices were 
cleaned in a solution of 2:1:1 v/v methanol:acetonitrile:isopropanol for 120 min. 
To characterize the prepared devices, scanning electron microscopy (SEM) images were taken 
using a LEO 1530 field emission (Carl Zeiss NTS GmbH, Germany), and microscope pictures were 
taken using an Olympus SZX10 stereomicroscope system equipped with a SC30 digital camera 
(Olympus, Japan). 
The previously described coating procedure was also followed to apply HLB-PAN, C18-PAN and 
only-PAN (without sorbent particles) coatings on flat PBT pieces (2 x 10 cm). These coated PBT  
pieces were subsequently used to investigate the wettability of these extraction phases. The 
wettability of these three coatings was assessed by measuring the contact angle of 30 µL water 
drops according to the sessile drop method. Images were acquired every 2 s, and contact angle 
measurements were collected using Axisymmetric Drop Shape Analysis (ADSA).
Sample preparation for LC-MS/MS analysis
An initial assessment of PBT as a substrate for the manufacture of thin-film SPME devices was 
carried  out  with the rounded pieces  (Figures  1A and 1B).  For  this  purpose,  PBS and three 
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different  biological  matrices (urine,  plasma, and whole blood) were used to test  the plastic 
devices.  Aliquots  (1080  µL)  of  each  matrix  were  spiked  with  methanolic  stock  solutions 
containing the model compounds. The organic solvent content was kept below 1 % in all cases. 
Once  spiked,  sample  pre-incubation  was  allowed  for  1  h  under  constant  vortex  agitation 
conditions to ensure proper equilibration between the model  compounds and the different 
tested matrices. Table 1 summarizes sample preparation parameters selected for urine, plasma, 
and blood analysis. These experimental conditions were chosen based on previous work done in 
our group.14,15 As can be seen, the same parameters used for plasma analysis were employed for 
extraction from whole blood, except for an additional washing step that was introduced after 
pre-conditioning, and three 5 s wash steps conducted after each extraction. In addition, a higher 
concentration of internal standard was used for blood and plasma samples compared to urine 
samples with the aim of compensating for low recoveries due to matrix binding effects. Since  
the number of SPME-HLB-PBT samplers on rounded PBT support was limited, matrix matched 
calibration curves were constructed for each biological fluid using one device per calibration 
level  (0.1,  0.25,  0.5,  1,  5,  10,  25,  50,  75,  and  100  ng  mL -1).  Accuracy  and  precision  were 
evaluated at 1.6, 15, 35, and 70 ng mL-1, using three devices per concentration level. Limits of 
quantification  (LOQ)  were  determined  as  the  lowest  concentration  points  at  which  both 
deviations from nominal concentration values and relative standard deviations were below 20 % 
for  each  individual  compound.  All  steps  of  the  SPME  method  were  carried  out  at  room 
temperature, and uniform stirring was conducted by placing the vials in a multi-tube vortex  
agitator. SPME-HLB-PBT devices on flat PBT support were employed to evaluate the robustness 
of the coating immobilized on the selected substrate. For this purpose, consecutive extractions 
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from plasma and whole blood spiked with six of the model compounds were performed using a 
set of  12 films arranged in the Concept  96 system (Figure  1 D).  For  this  part  of  the study, 
experimental conditions were kept as already described for whole blood analysis, except for 
extraction time and desorption volume, which were set at 60 min and 1200 µL, respectively. All  
extracts were analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). 
Full details concerning the LC gradient and monitored transitions are provided in the Supporting 
Information. 
Table 1. Summary of experimental conditions selected for SPME.
Parameter Urine Plasma Whole blood
Sample volume 1080 µl
Phosphate 
buffer (pH = 7)
120 µL (2 






15 µL of 8 µg mL-1 solution
Preconditioning 30 min in 1500 µL of 1:1 methanol:water
30 min in 1500 
µL of 1:1 
methanol:water 








3 times each in 
1500 µL of 
nanopure water 
for 5 s 
Desorption
20 min in 600 µL of 4:1 methanol: 




Characterization of PAN-HLB coating prepared on plastic and evaluation of PBT as a support 
for SPME
The optimized procedure for preparing thin-film PAN-based SPME coatings on a stainless steel 
support has been already reported.8 In that study, spraying over a previously etched surface and 
curing at 180 ˚C for 2 min were found to be optimum conditions. Due to the characteristics of  
the material selected as a new support for SPME devices, modifications to the already reported 
protocol were necessary. First of all, since etching with concentrated acid was not feasible, the 
plastic surface was only sanded with regular sandpaper. This step was taken with the aim of  
improving the adherence of the biocompatible coating on PBT. Secondly, considering that the 
maximum temperature for long term use of PBT is 125 ˚C, the coating curing procedure was  
conducted at 125 ˚C for 2.5 min. 
As can be seen in both the microscope picture and SEM image presented in Figures 1B and 1C, a  
uniformly coated surface was obtained. The robustness of the coated plastic devices was tested 
by exposing them to water, methanol, and acetonitrile for a total period of 20 h under constant 
vortex  agitation.  No  noticeable  changes  in  the  coating  structure  were  observed,  and  no 
detachment of the coating from the plastic surface occurred. These findings demonstrated the 
stability of the HLB-PAN layer immobilized on the newly proposed substrate and validated the 
selected  conditions  for  the  coating  procedure.  Provided that  no  etching  with  concentrated 
hydrochloric  acid  is  required,  a  simplified and greener  coating application approach can be 
established.
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After verifying the stability of the SPME coating on PBT, inter-device reproducibility was also 
assessed. Satisfactory results were obtained for 20 rounded devices employed to extract from 
spiked PBS, showing RSD values below 13 % for all the tested compounds (Figure S1, Supporting 
Information). However, it is worth noting that the rounded shape of the plastic support may 
have hindered the uniform application of the SPME coating by spraying. Although 13 % was an 
acceptable RSD value, better results were obtained when a flat support was used.
 
Figure 1. Rounded thin-film SPME devices prepared as described (A), microscope pictures of the 





coating on PBT support using 30x magnification (C) and SPME-HLB-PBT devices (on flat PBT 
support) in an arrangement compatible with the Concept 96 system (D).
Following the initial positive results obtained for the new coated material, an evaluation was 
conducted regarding possible interferences arising from the substrate that may be introduced 
into the sample or desorption media. For this purpose, an initial assessment of the background 
provided by the SPME coating prepared on the PBT support was carried out. Various new SPME-
HLB-PBT devices were desorbed in 4:1 methanol:acetonitrile (v/v) acidified with 0.1 % formic 
acid for 20 min. Prior to blank desorption, a cleaning step was performed by exposing the plastic 
devices to a mixture of organic solvents (2:1:1 v/v methanol :acetonitrile:isopropanol) under 
vortex agitation conditions for 120 min. Extracts were then run in full scan mode and compared 
with solvent blanks and extracts from the new HLB-PAN coatings prepared on a regular stainless 
steel.  As  can be seen in Figure  S2 (Supporting Information),  no significant  differences  were 
observed among the background signals obtained for all blanks. As a second means of verifying 
the absence of interferences coming from the proposed devices, absolute matrix effects were 
estimated according to the procedure proposed by Matuszewski et al.30 Extracts obtained from 
the desorption of blank SPME-HLB-PBT samplers were spiked with the target compounds at 50 
ng mL-1, and their response (peak area) was compared with the one from standards prepared in 
neat solvent at the same concentration level. Likewise, extracts from urine and plasma blanks 
obtained  with  SPME-HLB-PBT  devices  (n  =  6)  were  post-spiked  and  compared  with  neat 
standards as well. As shown in Table S4 (Supporting Information), no absolute matrix effects 
coming  from  the  devices  prepared  on  the  PBT  support  were  found  for  all  the  studied 
compounds.  In  addition,  no  significant  matrix  effects  (80  –  112  %)  were  observed  for  the 
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compounds spiked in urine and plasma blank extracts. These results demonstrated the stability 
of  the  SPME  coatings  on  the  polymeric  support,  while  proving  the  absence  of  possible 
interferences that might be released upon contact between the coated PBT and the sample 
medium or desorption solvent. 
Using SPME devices  on polymeric  support  for  the analysis  of  doping substances  in  urine, 
plasma, and blood
Urine and plasma analysis
The proposed rounded PBT devices were used for the analysis of urine and plasma samples 
according  to  the  experimental  conditions  provided  in  Table  1.  As  can  be  seen  in  Table  2, 
rewarding figures of merit were obtained when using SPME-HLB-PBT devices in both matrices. 
Satisfactory results  were observed for  most analyzed drugs,  with good linearity (R2 >  0.99), 
accuracy (80 – 120 %), and precision (RSD < 7%) measures. As expected, less polar compounds 
such  as  toremifene  (logP  6.56)  and  GW501516  (logP  6.46)  exhibited  higher  LOQ  values  in 
plasma than in urine due to protein binding effects. On the other hand, polar compounds such 
as salbutamol (log P 0.64) and morphine (log P 0.89), which are not significantly affected by 
protein binding interactions, showed the same LOQ values in both matrices. Indeed, the LOQ 
value for a given analyte is directly correlated to the absolute SPME recovery, which, in turn,  
depends on several  parameters,  namely, the extraction time, the convection conditions, the 
coating volume, and the affinity of the compound for the matrix components and for the SPME 
coating. Although in SPME a small amount of analyte proportional to the analyte concentration 
in the sample is extracted, depending on the previously listed factors and on the proportion 
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between coating and sample  volumes,  exhaustive,  or  almost  exhaustive extraction can take 
place. For some of the model compounds, this can be reflected in the higher enrichment factors  
(EF, analyte concentration in the extract/analyte concentration in the sample) estimated in urine 
compared to those EFs calculated in plasma or in whole blood (Table S5). In regards to urine  
results, it is also worth emphasizing that the LOQs determined complied with or were lower 
than the minimum required performance levels (MRPL) stipulated by WADA. For instance, the 
LOQ value determined for clenbuterol, the compound with the lowest MRPL (0.2 ng mL -1), not 
only fulfills WADA requirements but also allows for a quantification that is two times lower than 
the drug MRPL. Indeed, the observed differences between the LOQ values presented in this 
work and those already reported by BoyacI et al.14 and Reyes- Garcés et al.15 can be attributed to 
a  reduction in the desorption solvent volume (600  μL instead of  1200  μL),  a distinct  SPME 
coating volume (coated stainless steel blades vs. coated rounded devices) and, in the case of 
urine, the use of HLB particles instead of C18. Figure S3 shows representative chromatograms 
corresponding to extracts obtained from the different biofluids spiked at LOQ levels.
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Morphine (0.89) 0.1 0.9984 100 (0.1) 89 (1.0) 102 (1.4) 102 (0.4) 0.1 0.9958 116 (0.1) 107 (1.1) 92 (3.8) 110 (2.0)
Salbutamol (0.64) 0.1 0.9952 103 (0.1) 87 (0.7) 97 (0.9) 98 (1.7) 0.1 0.9936 109 (0.1) 104 (0.5) 103 (2.7) 108 (3.7)
Nikethamide (0.33) 0.5 0.9895 103 (0.1) 81 (1.5) 90 (1.7) 85 (1.7) 0.5 0.9986 100 (0.1) 102 (1.2) 100 (3.2) 104 (5.3)
Codeine (1.19) 0.1 0.9977 101 (0.1) 87 (0.5) 103 (1.1) 101 (1.0) 0.1 0.994 109 (0.1) 104 (0.4) 105 (2.7) 109 (3.9)
Benzoylecgonine (2.71) 0.5 0.9978 99 (0.1) 86 (1.8) 114 (0.8) 107 (3.0) 1 0.9993 87 (0.3) 110 (2.5) 107 (3.9) 113 (3.2)
Amphetamine (1.76) 0.25 0.9935 95 (0.1) 82 (1.4) 88 (1.6) 94 (3.8) 0.25 0.9919 105 (0.2) 104 (0.7) 112 (3.1) 99 (2.5)
Methamphetamine (2.07) 0.1 0.9928 94 (0.1) 84 (2.1) 89 (1.4) 94 (3.4) 0.25 0.9909 105 (0.2) 103 (0.9) 115 (2.5) 98 (4.2)
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Strychnine (1.93) 0.5 0.9959 94 (0.1) 85 (1.9) 103 (1.6) 99 (4.6) 5 0.9935 - 121 (0.7) 94 (3.8) 116 (5.5)
Exemestane (3.11) 1 0.9975b 107 (0.1) 87 (0.8) 88 (1.1) 108 (3.2) 1 0.9922 118 (0.2) 106 (1.0) 112 (2.2) 111 (4.7)
Trenbolone (2.27) 1 0.9958b 104 (0.2) 74 (0.6) 81 (0.5) 98 (7.8) 1 0.9922 107 (0.1) 105 (1.0) 105 (4.4) 105 (4.8)
Metoprolol (1.88) 0.25 0.9940 102 (0.1) 84 (0.6) 102 (1.9) 88 (2.3) 0.25 0.9982 107 (0.1) 107 (0.4) 112 (3.1) 109 (4.6)
Stanozolol (4.42) 0.1 0.9997b 94 (0.1) 81 (0.5) 87 (1.0) 105 (2.7) 5 0.9843 - 95 (0.4) 102 (3.2) 93 (4.4)
Clenbuterol (2.61) 0.1 0.9906 102 (0.1) 86 (1.0) 106 (1.7) 95 (1.6) 1 0.9968 79 (1.3) 123 (1.5) 105 (2.9) 118 (5.7)
Bisoprolol (1.89) 0.1 0.9953 93 (0.1) 82 (1.1) 103 (2.2) 86 (3.5) 0.5 0.9951 79 (1.0) 116 (0.7) 118 (2.7) 112 (5.7)
GW501516 (6.46) 0.1 0.9963 96 (0.4) 80 (1.8) 80 (4.9) 96 (3.9) 5 0.9940 - 98 (0.5) 98 (3.2) 103 (1.7)
Propranolol (3.48) 0.1 0.9913 91 (0.1) 74 (2.0) 93 (1.7) 86 (3.1) 5 0.9952 - 110 (0.9) 101 (3.4) 112 (2.1)
Toremifene (6.56) 1 0.9959 105 (0.2) 75 (1.3) 72 (4.8) 96 (6.5) 5 0.9976 - 85 (2.0) 101 (3.4) 118 (5.3)
Regression coefficients were calculated using LOQ values and 100 ng mL -1 as the lowest and highest 
calibration points, respectively.
a log P values were taken from Chemspider31
b Highest calibration point was 75 ng mL-1
Whole blood analysis
Due to the high content of proteins and the presence of red blood cells, using whole blood as a 
matrix is more challenging and subsequently less common than analyzing serum and plasma. 
Based on the already discussed results corresponding to urine and plasma, the suitability of 
SPME-HLB-PBT devices for whole blood analysis was also investigated. 
A previous study published by Mirnaghi and Pawliszyn in 2012 reported irreversible attachment 
of red blood cells to C18-PAN thin-film SPME devices when they undergo direct immersion in 
whole blood using the Concept 96 workstation system.29 As a feasible solution to this problem, 
and looking toward coating reusability in an automated fashion, a modified extraction phase 
consisting of an external layer of PAN over a C18-PAN coating was proposed.29 This approach 
considerably  improved  the  coating  compatibility  with  blood  and  enabled  its  reusability  for 
multiple  extractions  in  such  a  complex  matrix.  However,  it  is  worth  emphasizing  that  the 
presence of the extra PAN layer leads to a decrease in extraction kinetics, and therefore affects  
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method sensitivity, especially at pre-equilibrium conditions. Figure S4 (Supporting Information) 
shows a comparison of the absolute recoveries obtained for six of the model compounds, using 
SPME-HLB-PBT devices prepared on flat support with and without a PAN over-coating (applied 
by dipping). As can be seen, a decrease of more than 70 % for some of the analytes was found 
due to the over-coating PAN layer. Given that in this case, potential application of the proposed 
devices as single use samplers is being considered, a different approach to test the rounded PBT 
coated pieces in whole blood analysis was taken. 
The typical  SPME workflow was modified by introducing three additional  washing steps,  as 
described in Table 1. A washing step was implemented after preconditioning in order to remove 
any  excess  organic  solvent  remaining  on  the  coating.  This  prevented  possible  protein 
precipitation or cell  disruption from occurring on the extraction phase when the wet SPME 
coating got in contact with the whole blood matrix. Three wash steps of 5 s were also conducted 
after direct blood extraction (each wash step was performed in a new vial with clean water). It is  
worth highlighting that an evaluation of four different washing approaches (10 s static, 10 s with 
vortex agitation, two washing steps of 5 s with vortex agitation and three washing steps of 5 s 
with vortex agitation) showed that three consecutive washing steps did not cause any significant 
losses for any of the studied compounds for SPME devices coated with HLB particles (see Figure 
S5, Supporting Information). Indeed, the washing step should be carefully optimized according 
to the SPME coating selected and the analytes of interest. For example, in the case of the HLB-
PAN, it is expected to observe high affinity toward compounds bearing on their structures lone 
electron  pairs  and  able  to  display  π-π  interactions  with  the  divinylbenzene  moiety.32,33 The 
almost exhaustive recoveries provided by HLB-PAN coating when used for the extraction of basic 
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(e.g. clenbuterol, bisoprolol, and propranolol) and steroidal analytes (e.g. 17-α-trenbolone and 
stanozolol) from PBS (Figure S5) are in agreement with other reports where the properties of 
HLB as SPE sorbent were investigated.34,35 It is also worth to emphasize that, among the model 
compounds, salbutamol presented the lowest absolute recovery. Albeit for this compound a 
lower  distribution  coefficient  is  predictable  due  to  its  high  hydrophilicity  and  degree  of 
ionization, reproducible recoveries, even after several washing steps, were still attained.
By following this modified SPME procedure, analytical  figures of merit in whole blood were 
investigated. As can be seen in Table 3, satisfactory results in terms of linearity, LOQ, accuracy, 
and  precision  were  obtained  for  all  prohibited  drugs  under  analysis.  These  findings  also 
reflected the absence of irreversible fouling which, as already reported by several authors, can 
affect the kinetics of extraction with SPME.36–38 SEM images and microscope pictures of the HLB 
coating after exposure to blood for 90 min (Figure S6, Supporting Information) confirmed that 
irreversible protein attachment on the coating surface did not take place. In this regard, it is 
important to note that the feasibility of using the proposed devices for direct immersion in 
whole blood without any PAN over-coating layer may be related to the agitation conditions, the 
composition of the slurry employed to prepare the devices (lower SPE particles/PAN solution 
ratio compared to previous reports8), as well as the dimensions and rounded shape of the PBT 
support. In point of fact, shear stress imparted by blood flow conditions has been reported as a 
critical factor in determining whether a device is blood compatible.39–42 The vigorous agitation 
provided by the multi-tube vortex system, together with the rounded shape and the specific 
dimensions  of  the  coated  devices  (2.0  mm  diameter),  might  have  led  to  different  shear 
conditions  from  those  normally  encountered  when  using  the  Concept  96  under  its  typical 
19
operational configuration. Another aspect that should be also taken into account is that the 
evaluation of plastic devices was carried out in vials. Whole blood, when exposed to an open 
environment for a substantial period of time, as it occurs when using the Concept 96 system, is  
more prone to undergo alterations compared to blood that remains capped in a vial during the 
extraction process.41 For  this reason, additional considerations should be taken into account 
when expecting  an  antifouling  SPME  extraction  phase  at  such  conditions  (e.g.  using  SPME 
coatings with an extra layer of PAN). Overall, the results demonstrated high blood compatibility 
for  both  the coating and support  employed at  the selected experimental  condition for  the 
proposed devices.
The presence of an absolute matrix effect after extracting from whole blood was assessed in the 
same manner reported for urine and plasma (Table S6, Supporting Information). As presented in 
Table  S6,  no  significant  ion  suppression/enhancement  was  found  for  any  of  the  evaluated 
compounds  at  the  selected  experimental  conditions.  Indeed,  using  vortex  stirring  for  the 
washing steps provided very effective cleaning/removal of possible interferences due to the 
strong agitation provided by the vortex. As a second approach to verify the performance of the 
plastic SPME devices in terms of analytical specificity at the tested conditions, transition ratios 
were  also  calculated  for  all  the  evaluated  biofluids.  In  quantitative  analysis  using  mass 
spectrometry, the ratio between qualifier and quantifier transition signals should be the same 
for  both  the  standards  and  biological  samples.43 Results  presented  in  Table  S7  (Supporting 
Information) evidenced an overall satisfactory performance of the proposed methodology for 
the  majority  of  the  model  compounds.  Only  trenbolone  extracted  from  blood  showed  a 
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significant deviation from the ratio calculated in standard; however, this may be overcome by 
improving the separation conditions. 




 ng mL-1 R
2









Morphine (0.89) 0.1 0.9984 107 (0.1) 102 (1.0) 99 (1.4) 108 (6.0)
Salbutamol (0.64) 0.1 0.9992 102 (0.1) 100 (0.3) 95 (0.7) 105 (5.0)
Nikethamide (0.33) 0.5 0.9993 110 (0.1) 101 (1.3) 91 (1.2) 106 (2.3)
Codeine (1.19) 0.1 0.9992 101 (0.1) 98 (0.3) 95 (0.5) 105 (5.5)
Benzoylecgonine (2.71) 0.5 0.9992 122 (0.2) 109 (2.0) 102 (1.7) 117 (10.6)
Amphetamine (1.76) 1 0.9994 86 (0.1) 101 (0.7) 94 (1.9) 106 (4.6)
Methamphetamine (2.07) 1 0.9987 83 (0.1) 104 (1.1) 95 (1.6) 108 (2.9)
Strychnine (1.93) 5 0.9980 - 103 (0.3) 97 (1.0) 103 (5.4)
Exemestane (3.11) 1 0.9988 87 (0.2) 94 (0.8) 95 (0.1) 104 (5.6)
Trenbolone (2.27) 1 0.9994 88 (0.1) 94 (0.5) 90 (0.9) 100 (6.8)
Metoprolol (1.88) 0.25 0.9970 97 (0.1) 99 (0.3) 94 (1.2) 100 (6.0)
Stanozolol (4.42) 5 0.9944 - 105 (2.2) 99 (3.5) 110 (5.4)
Clenbuterol (2.61) 1 0.9982 80 (0.1) 102 (0.3) 95 (0.8) 102 (5.7)
Bisoprolol (1.89) 0.25 0.9964 94 (0.1) 98 (0.5) 92 (0.5) 99 (6.4)
GW501516 (6.46) 5 0.9945 - 95 (0.5) 91 (2.6) 98 (5.2)
Propranolol (3.48) 5 0.9958 - 106 (0.9) 94 (0.4) 102 (7.5)
Toremifene (6.56) 5 0.9956 - 102 (1.8) 88 (3.1) 107 (10.0)
Regression coefficients were calculated using the LOQ value and 100 ng mL-1 as the lowest and highest 
calibration points, respectively.
a log P values were taken from Chemspider31
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Assessment of HLB-PAN coating wettability
Figure  2. Water  contact  angles  for  HLB-PAN,  C18-PAN and  only-PAN coatings.  Images  were 
acquired every 2 s over a 10 min period.
Surface wettability has been traditionally conceived as an essential parameter in the design of 
materials with efficient resistance to protein fouling.44,45 However, a direct relationship between 
low water contact angles (increasing wettability) and negligible protein adsorption or material 
biocompatibility has not been found in all the studied cases.39,45–47 Despite this, determining the 
degree  of  wettability  of  PAN-based  SPME  coatings  may  provide  important  information 
considering  the  aqueous  nature  of  biofluids.  Indeed,  easily  wettable  extraction  phases  are 
expected to facilitate the sample-coating interaction during the extraction process.  Figure 2 
shows the water contact angle variation over time found for HLB-PAN, C18-PAN and only-PAN 
coatings. Prior to the contact angle measurements, the HLB-PAN and C18-PAN surfaces were 
conditioned in a 1:1 methanol:water solution for 10 min, wiped with Kimwipes, and allowed to 
dry for approximately 10 min. As can be seen in Figure 2, although PAN was used as a binder in  
all the tested surfaces, HLB particles imparted a high degree of wettability to the coating. On the 
other hand, C18 conferred significant hydrophobicity to the extraction phase, yielding estimated 
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water  contact  angles  above  100˚  over  the  entire  measurement  time.  In  relation  to  SPME 
extraction phases, these results suggest that using HLB combined with PAN, or even using other 
wettable materials, may provide improved performance compared to other sorbents, such as 
C18, when dealing with biological samples. As such, the development of SPME devices intended 
for spot sampling or even for  in vivo sampling, where convection is certainly restricted, may 
need to include the determination of coating wettability as an important criterion. 
Evaluation of the robustness and reusability of SPME thin-film devices prepared on plastic 
substrate using high-throughput configuration.
After verifying the suitability of PBT as a substrate for SPME devices, the robustness of the PAN-
based coatings prepared on the new support was evaluated through multiple extractions from 
plasma and whole blood. Although there are cases where single-use samplers are certainly 
required, other analytical applications might be more flexible, and reusable SPME devices are a 
most  convenient  and cost-effective option.  To validate  the suitability  of  the new device  for 
multiple  use  applications,  SPME-HLB-PBT samplers  made on flat  support  (with  and without 
over-coating) were arranged in a Concept 96-compatible fashion, as shown in Figure 1D. Given 
that  these devices were prepared by coating a PBT surface that  was subsequently  cut  into 
smaller pieces, an initial assessment of inter-thin-film reproducibility was carried out. As can be 
seen in Table S8 (Supporting Information), RSD values below 7 and 3.5 % (n=6) were found for 
SPME devices with and without PAN over-coating, respectively. In addition to carrying out an 
assessment of inter-device reproducibility, SPME-HLB-PBT samplers were physically inspected by 
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taking microscope pictures of the coatings and of the interface between the coating and the 
plastic support (Figure S7, Supporting Information). The obtained images of the lateral view of 
the devices confirm that good attachment was achieved between the PAN-based coatings and 
the PBT surface. It is worth highlighting that even after undergoing a cutting process, the SPME 
coating remained firmly adhered to the polymeric material. Regarding reusability, no statistical  
differences were observed between recovery values obtained in the first and twentieth trials  
performed in plasma (Figure 3). In the case of whole blood, propranolol and stanozolol showed 
a  slightly  lower  recovery  during  the  first  extraction  when  compared  to  all  subsequent 
experiments. This observed outcome may be due to the extra layer of PAN applied to the HLB 
coating  which,  in  addition  to  slowing  down the  extraction  kinetics,  might  require  that  the 
overcoated HLB coating receive more extensive conditioning in comparison to coatings without 
this over-coating; however, this effect was observed only for the two less polar drugs tested.  
Overall,  the  obtained  results  suggest  that  using  PBT  as  a  substrate  may  provide  the  same 
coating robustness and stability obtained with the use of etched stainless steel. 
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Figure 3.  Evaluation of  the stability and robustness of  the HLB-PAN coating applied on PBT 
support. Consecutive extractions were performed from plasma (A) and whole blood (B) spiked 
at  70  ng  mL-1 and  mixed  with  1  M  phosphate  buffer  in  a  9:1  ratio  (sample:buffer)  (n=6).  
Extractions from whole blood were carried out using HLB thin-films with PAN-over coating.
Conclusions
In this work, the suitability of PBT as a support to manufacture SPME devices that could be 
potentially employed as disposable samplers was demonstrated. Robust PAN-HLB coatings, free 
of background interferences and able to stand exposure to organic solvents for long periods of 
time, were attained by following a modified coating preparation procedure. Since no etching 
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with  hydrochloric  acid  was  required,  a  greener  manufacturing  process  with  a  reduced 
production of chemical waste was possible. Rewarding figures of merit were found when these 
SPME samplers  were  used for  quantitative  analysis  of  multiple  doping  substances  in  urine, 
plasma,  and  whole  blood.  LOQ  values  determined  in  urine  met  or  were  below  the  MRPL 
requirements set by WADA. In the case of plasma and whole blood, LOQ levels were in the low 
ng mL-1 which is within the range of expected concentrations in such matrices.48 Absence of an 
absolute  matrix  effect  in  extracts  obtained from the three tested  biofluids  proved that  the 
SPME-HLB-PBT devices provided satisfactory sample clean-up. Indeed, whole blood analysis was 
facilitated  by  utilizing  rounded SPME-HLB-PBT devices  together  with the implementation of 
multiple washing steps and vortex agitation conditions.  HLB-PAN was demonstrated to be a 
more easily wettable coating than C18-PAN, which may be an important criterion to consider 
when developing disposable devices for spot sampling. The high stability of the biocompatible 
coating applied on PBT permitted the cutting of smaller portions from an already large coated 
piece, which may be convenient in cases where tailor-made sizes are needed. Although these 
devices  were  developed  considering  the  concept  of  single-use,  they  can  be  re-used  in 
applications where carryover at trace levels does not represent a serious concern. Overall, the 
introduction of alternative materials, such as polymeric substrates, may represent an important 
opportunity  for  new  advances  in  the  commercialization  and  acceptance  of  SPME  in  the 
bioanalytical field. Besides traditional fiber and flat thin-film configurations, the development of 
other SPME geometries may be facilitated by integrating new materials as supports,  and by 
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